Literature DB >> 16820649

Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle.

Hiroshi Naito1, Ivan Melnychenko, Michael Didié, Karin Schneiderbanger, Pia Schubert, Stephan Rosenkranz, Thomas Eschenhagen, Wolfram-Hubertus Zimmermann.   

Abstract

BACKGROUND: Cardiac tissue engineering aims at providing heart muscle for cardiac regeneration. Here, we hypothesized that engineered heart tissue (EHT) can be improved by using mixed heart cell populations, culture in defined serum-free and Matrigel-free conditions, and fusion of single-unit EHTs to multi-unit heart muscle surrogates. METHODS AND
RESULTS: EHTs were constructed from native and cardiac myocyte enriched heart cell populations. The former demonstrated a superior contractile performance and developed vascular structures. Peptide growth factor-supplemented culture medium was developed to maintain contractile EHTs in a serum-free environment. Addition of triiodothyronine and insulin facilitated withdrawal of Matrigel from the EHT reconstitution mixture. Single-unit EHTs could be fused to form large multi-unit EHTs with variable geometries.
CONCLUSIONS: Simulating a native heart cell environment in EHTs leads to improved function and formation of primitive capillaries. The latter may constitute a preformed vascular bed in vitro and facilitate engraftment in vivo. Serum- and Matrigel-free culture conditions are expected to reduce immunogenicity of EHT. Fusion of single-unit EHT allows production of large heart muscle constructs that may eventually serve as optimized tissue grafts in cardiac regeneration in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16820649     DOI: 10.1161/CIRCULATIONAHA.105.001560

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  104 in total

1.  A microfabricated platform to measure and manipulate the mechanics of engineered cardiac microtissues.

Authors:  Thomas Boudou; Wesley R Legant; Anbin Mu; Michael A Borochin; Nimalan Thavandiran; Milica Radisic; Peter W Zandstra; Jonathan A Epstein; Kenneth B Margulies; Christopher S Chen
Journal:  Tissue Eng Part A       Date:  2012-01-04       Impact factor: 3.845

Review 2.  Getting to the heart of tissue engineering.

Authors:  Luda Khait; Louise Hecker; Nicole R Blan; Garrett Coyan; Francesco Migneco; Yen-Chih Huang; Ravi K Birla
Journal:  J Cardiovasc Transl Res       Date:  2008-01-29       Impact factor: 4.132

3.  A novel miniaturized multimodal bioreactor for continuous in situ assessment of bioartificial cardiac tissue during stimulation and maturation.

Authors:  George Kensah; Ina Gruh; Jörg Viering; Henning Schumann; Julia Dahlmann; Heiko Meyer; David Skvorc; Antonia Bär; Payam Akhyari; Alexander Heisterkamp; Axel Haverich; Ulrich Martin
Journal:  Tissue Eng Part C Methods       Date:  2011-01-14       Impact factor: 3.056

4.  Engineered fetal cardiac graft preserves its cardiomyocyte proliferation within postinfarcted myocardium and sustains cardiac function.

Authors:  Kazuro L Fujimoto; Kelly C Clause; Li J Liu; Joseph P Tinney; Shivam Verma; William R Wagner; Bradley B Keller; Kimimasa Tobita
Journal:  Tissue Eng Part A       Date:  2011-01-16       Impact factor: 3.845

5.  A modular approach to cardiac tissue engineering.

Authors:  Brendan M Leung; Michael V Sefton
Journal:  Tissue Eng Part A       Date:  2010-10       Impact factor: 3.845

Review 6.  Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues.

Authors:  Nicole T Feric; Milica Radisic
Journal:  Adv Drug Deliv Rev       Date:  2015-05-05       Impact factor: 15.470

7.  Spatiotemporal tracking of cells in tissue-engineered cardiac organoids.

Authors:  Rohin K Iyer; Jane Chui; Milica Radisic
Journal:  J Tissue Eng Regen Med       Date:  2009-03       Impact factor: 3.963

8.  Engineered skeletal muscle tissue networks with controllable architecture.

Authors:  Weining Bian; Nenad Bursac
Journal:  Biomaterials       Date:  2008-12-12       Impact factor: 12.479

9.  Cardiac fibroblasts support endothelial cell proliferation and sprout formation but not the development of multicellular sprouts in a fibrin gel co-culture model.

Authors:  Rachel L Twardowski; Lauren D Black
Journal:  Ann Biomed Eng       Date:  2014-01-17       Impact factor: 3.934

Review 10.  Characterizing functional stem cell-cardiomyocyte interactions.

Authors:  Nenad Bursac; Robert D Kirkton; Luke C McSpadden; Brian Liau
Journal:  Regen Med       Date:  2010-01       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.